Brief: Enorama Pharma Explores Divestment Of Nicotine Replacement Therapy Chewing Gum Business

Enorama Pharma AB

25/09/2024 11:02

Sept 25 (Reuters) - Enorama Pharma AB  ERMA.ST :
    * EXPLORES DIVESTMENT OF NICOTINE REPLACEMENT THERAPY
CHEWING GUM
BUSINESS
    * TO FOCUS ON CONTINUED EXPANSION OF ITS NIC-S NICOTINE
POUCH
PRODUCT LINE
    * IF FINANCIAL TERMS OF DIVESTMENT ARE FAVORABLE, WE PLAN TO
CONCENTRATE FULLY ON EXPANDING OUR POUCH BUSINESS, INCLUDING
MARKETS OUTSIDE U.S. - CEO

Source text for Eikon:  ID:nWkr1G0gJq 
Further company coverage:  ERMA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))